AAAAAA
Results:
1-22
|
Results: 22
Authors:
DANKS MK
WHIPPLE DO
MCPAKE CR
LU DY
HARRIS LC
Citation: Mk. Danks et al., DIFFERENCES IN EPITOPE ACCESSIBILITY OF P53 MONOCLONAL-ANTIBODIES SUGGEST AT LEAST 3 CONFORMATIONS OR STATES OF PROTEIN-BINDING OF P53 PROTEIN IN HUMAN TUMOR-CELL LINES, Cell death and differentiation, 5(8), 1998, pp. 678-686
Authors:
PAWLIK CA
HOUGHTON PJ
STEWART CF
CHESHIRE PJ
RICHMOND LB
DANKS MK
Citation: Ca. Pawlik et al., EFFECTIVE SCHEDULES OF EXPOSURE OF MEDULLOBLASTOMA AND RHABDOMYOSARCOMA XENOGRAFTS TO TOPOTECAN CORRELATE WITH IN-VITRO ASSAYS, Clinical cancer research, 4(8), 1998, pp. 1995-2002
Authors:
ZAMBONI WC
GAJJAR AJ
MANDRELL TD
EINHAUS SL
DANKS MK
ROGERS WP
HEIDEMAN RL
HOUGHTON PJ
STEWART CF
Citation: Wc. Zamboni et al., A 4-HOUR TOPOTECAN INFUSION ACHIEVES CYTOTOXIC EXPOSURE THROUGHOUT THE NEURAXIS IN THE NONHUMAN PRIMATE MODEL - IMPLICATIONS FOR TREATMENT OF CHILDREN WITH METASTATIC MEDULLOBLASTOMA, Clinical cancer research, 4(10), 1998, pp. 2537-2544
Authors:
POTTER PM
WOLVERTON JS
MORTON CL
WHIPPLE DO
DANKS MK
Citation: Pm. Potter et al., IN-SITU SUBCELLULAR-LOCALIZATION OF EPITOPE-TAGGED HUMAN AND RABBIT CARBOXYLESTERASES, Cytometry, 32(3), 1998, pp. 223-232
Authors:
HOSOI H
DILLING MB
LIU LN
DANKS MK
SHIKATA T
SEKULIC A
ABRAHAM RT
LAWRENCE JC
HOUGHTON PJ
Citation: H. Hosoi et al., STUDIES ON THE MECHANISM OF RESISTANCE TO RAPAMYCIN IN HUMAN CANCER-CELLS, Molecular pharmacology, 54(5), 1998, pp. 815-824
Authors:
WADKINS RM
DANKS MK
HOROWITZ L
BAKER SD
Citation: Rm. Wadkins et al., CHARACTERIZATION OF TOPOTECAN-MEDIATED REDISTRIBUTION OF DNA TOPOISOMERASE-I BY DIGITAL IMAGING MICROSCOPY, Experimental cell research, 241(2), 1998, pp. 332-339
Authors:
POTTER PM
WOLVERTON JS
MORTON CL
WIERDL M
DANKS MK
Citation: Pm. Potter et al., CELLULAR-LOCALIZATION DOMAINS OF A RABBIT AND A HUMAN CARBOXYLESTERASE - INFLUENCE ON IRINOTECAN (CPT-11) METABOLISM BY THE RABBIT ENZYME, Cancer research, 58(16), 1998, pp. 3627-3632
Authors:
POTTER PM
PAWLIK CA
MORTON CL
NAEVE CW
DANKS MK
Citation: Pm. Potter et al., ISOLATION AND PARTIAL CHARACTERIZATION OF A CDNA-ENCODING A RABBIT LIVER CARBOXYLESTERASE THAT ACTIVATES THE PRODRUG IRINOTECAN (CPT-11), Cancer research, 58(12), 1998, pp. 2646-2651
Authors:
DANKS MK
MORTON CL
PAWLIK CA
POTTER PM
Citation: Mk. Danks et al., OVEREXPRESSION OF A RABBIT LIVER CARBOXYLESTERASE SENSITIZES HUMAN TUMOR-CELLS TO CPT-11, Cancer research, 58(1), 1998, pp. 20-22
Authors:
DANKS MK
PAWLIK CA
WHIPPLE DO
WOLVERTON JS
Citation: Mk. Danks et al., INTERMITTENT EXPOSURE OF MEDULLOBLASTOMA CELLS TO TOPOTECAN PRODUCES GROWTH-INHIBITION EQUIVALENT TO CONTINUOUS EXPOSURE, Clinical cancer research, 3(10), 1997, pp. 1731-1738
Authors:
KELLNER U
HUTCHINSON L
SEIDEL A
LAGE H
DANKS MK
DIETEL M
KAUFMANN SH
Citation: U. Kellner et al., DECREASED DRUG ACCUMULATION IN A MITOXANTRONE-RESISTANT GASTRIC-CARCINOMA CELL-LINE IN THE ABSENCE OF P-GLYCOPROTEIN, International journal of cancer, 71(5), 1997, pp. 817-824
Authors:
BECK WT
DANKS MK
WOLVERTON JS
Citation: Wt. Beck et al., FINDING THE DRUG-RESISTANT TUMOR-CELL BY MOLECULAR AND CELLULAR-ASSAYS - THE ALTERED TOPOISOMERASE PARADIGM - ASSAYS FOR DRUG-RESISTANCE, Onkologie, 19, 1996, pp. 14-18
Authors:
DANKS MK
GARRETT KE
MARION RC
WHIPPLE DO
Citation: Mk. Danks et al., SUBCELLULAR REDISTRIBUTION OF DNA TOPOISOMERASE-I IN ANAPLASTIC ASTROCYTOMA-CELLS TREATED WITH TOPOTECAN, Cancer research, 56(7), 1996, pp. 1664-1673
Authors:
HASHIMOTO S
DANKS MK
CHATTERJEE S
BECK WT
BERGER NA
Citation: S. Hashimoto et al., A NOVEL POINT MUTATION IN THE 3'-PLANKING REGION OF THE DNA-BINDING DOMAIN OF TOPOISOMERASE-II-ALPHA ASSOCIATED WITH ACQUIRED-RESISTANCE TOTOPOISOMERASE-II ACTIVE AGENTS, Oncology research, 7(1), 1995, pp. 21-29
Authors:
HOUGHTON PJ
CHESHIRE PJ
HALLMAN JD
LUTZ L
FRIEDMAN HS
DANKS MK
HOUGHTON JA
Citation: Pj. Houghton et al., EFFICACY OF TOPOISOMERASE-I INHIBITORS, TOPOTECAN AND IRINOTECAN, ADMINISTERED AT LOW-DOSE LEVELS IN PROTRACTED SCHEDULES TO MICE BEARING XENOGRAFTS OF HUMAN TUMORS, Cancer chemotherapy and pharmacology, 36(5), 1995, pp. 393-403
Authors:
BAKER SD
WADKINS RM
STEWART CF
BECK WT
DANKS MK
Citation: Sd. Baker et al., CELL-CYCLE ANALYSIS OF AMOUNT AND DISTRIBUTION OF NUCLEAR-DNA TOPOISOMERASE-I AS DETERMINED BY FLUORESCENCE DIGITAL IMAGING MICROSCOPY, Cytometry, 19(2), 1995, pp. 134-145
Authors:
EVANS CD
MIRSKI SEL
DANKS MK
COLE SPC
Citation: Cd. Evans et al., REDUCED LEVELS OF TOPOISOMERASE II-ALPHA AND II-BETA IN A MULTIDRUG-RESISTANT LUNG-CANCER CELL-LINE, Cancer chemotherapy and pharmacology, 34(3), 1994, pp. 242-248
Authors:
HOSKING LK
WHELAN RDH
SHELLARD SA
DAVIES SL
HICKSON ID
DANKS MK
HILL BT
Citation: Lk. Hosking et al., MULTIPLE MECHANISMS OF RESISTANCE IN A SERIES OF HUMAN TESTICULAR TERATOMA CELL-LINES SELECTED FOR INCREASING RESISTANCE TO ETOPOSIDE, International journal of cancer, 57(2), 1994, pp. 259-267
Authors:
DANKS MK
QIU J
CATAPANO CV
SCHMIDT CA
BECK WT
FERNANDES DJ
Citation: Mk. Danks et al., SUBCELLULAR-DISTRIBUTION OF THE ALPHA-TOPOISOMERASE-II AND BETA-TOPOISOMERASE-II DNA COMPLEXES STABILIZED BY VM-26, Biochemical pharmacology, 48(9), 1994, pp. 1785-1795
Authors:
BECK WT
DANKS MK
WOLVERTON JS
GRANZEN B
CHEN M
SCHMIDT CA
BUGG BY
FRICHE E
SUTTLE DP
Citation: Wt. Beck et al., ALTERED DNA TOPOISOMERASE-II IN MULTIDRUG-RESISTANCE, Cytotechnology, 11(2), 1993, pp. 115-119
Authors:
HILL AB
TRENT JM
THOMPSON FH
DANKS MK
BECK WT
Citation: Ab. Hill et al., LOSS OF TUMORIGENICITY IN A METHOTREXATE-RESISTANT HUMAN LEUKEMIA-CELL LINE, Cancer genetics and cytogenetics, 70(1), 1993, pp. 48-55
Authors:
GRANZEN B
GRAVES DE
BAGULEY BC
DANKS MK
BECK WT
Citation: B. Granzen et al., STRUCTURE-ACTIVITY STUDIES OF AMSACRINE ANALOGS IN DRUG-RESISTANT HUMAN LEUKEMIA-CELL LINES EXPRESSING EITHER ALTERED DNA TOPOISOMERASE-II OR P-GLYCOPROTEIN, Oncology research, 4(11-12), 1992, pp. 489-496
Risultati:
1-22
|